FI3955899T3 - Pitkäaikaisesti vakaa, elävä mikrobiotakoostumus - Google Patents

Pitkäaikaisesti vakaa, elävä mikrobiotakoostumus

Info

Publication number
FI3955899T3
FI3955899T3 FIEP20716843.6T FI20716843T FI3955899T3 FI 3955899 T3 FI3955899 T3 FI 3955899T3 FI 20716843 T FI20716843 T FI 20716843T FI 3955899 T3 FI3955899 T3 FI 3955899T3
Authority
FI
Finland
Prior art keywords
water
composition according
absorbing
cellulose
microorganisms
Prior art date
Application number
FIEP20716843.6T
Other languages
English (en)
Finnish (fi)
Inventor
Negre Josep M Suñé
Viladomiu Alex Soriano
Gomez Andrea Aira
Csaba Feher
Original Assignee
Fundacio De Recerca Clinic Barcelona Inst Dinvestigacions Biomediques August Pi I Sunyer Frcb Idibap
Hospital Clinic Barcelona
Univ Barcelona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacio De Recerca Clinic Barcelona Inst Dinvestigacions Biomediques August Pi I Sunyer Frcb Idibap, Hospital Clinic Barcelona, Univ Barcelona filed Critical Fundacio De Recerca Clinic Barcelona Inst Dinvestigacions Biomediques August Pi I Sunyer Frcb Idibap
Application granted granted Critical
Publication of FI3955899T3 publication Critical patent/FI3955899T3/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FIEP20716843.6T 2019-04-15 2020-04-14 Pitkäaikaisesti vakaa, elävä mikrobiotakoostumus FI3955899T3 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19382287 2019-04-15
PCT/EP2020/060370 WO2020212297A1 (en) 2019-04-15 2020-04-14 Long-term stable live fecal microbiota composition

Publications (1)

Publication Number Publication Date
FI3955899T3 true FI3955899T3 (fi) 2025-07-28

Family

ID=66349477

Family Applications (1)

Application Number Title Priority Date Filing Date
FIEP20716843.6T FI3955899T3 (fi) 2019-04-15 2020-04-14 Pitkäaikaisesti vakaa, elävä mikrobiotakoostumus

Country Status (19)

Country Link
US (2) US20220143107A1 (https=)
EP (2) EP3955899B1 (https=)
JP (1) JP2022529008A (https=)
KR (1) KR20210152505A (https=)
CN (1) CN113710237B (https=)
AU (1) AU2020259740B2 (https=)
BR (1) BR112021020606A2 (https=)
CA (1) CA3130816A1 (https=)
DK (1) DK3955899T3 (https=)
EA (1) EA202192291A1 (https=)
ES (1) ES3035981T3 (https=)
FI (1) FI3955899T3 (https=)
IL (1) IL287238A (https=)
MX (1) MX2021011246A (https=)
PH (1) PH12021552573A1 (https=)
PL (1) PL3955899T3 (https=)
PT (1) PT3955899T (https=)
SG (1) SG11202110641XA (https=)
WO (1) WO2020212297A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017024265B1 (pt) 2015-05-11 2022-08-09 Mybiotics Pharma Ltd Métodos para crescimento de um biofilme de bactérias probióticas em partículas sólidas
IL294171A (en) 2016-05-25 2022-08-01 Mybiotics Pharma Ltd Composition and methods for microbiota therapy
EP3955899B1 (en) 2019-04-15 2025-05-07 Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS) Long-term stable live microbiota composition

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1190386A (en) * 1966-06-28 1970-05-06 Green Cross Corp Process for producing the Lactic Acid Bacteria Drugs
FR2708621B1 (fr) * 1993-07-29 1995-10-20 Lesaffre & Cie Biomasse stable à base de cellules de levure et de bactéries lactiques et procédé de préparation.
ITMI20011632A1 (it) 2001-07-27 2003-01-27 Sanofi Synthelabo Composizione solida contenente spore di batteri non patogeni del genere bacillus
US20050266069A1 (en) 2002-09-06 2005-12-01 Simmons Donald L Stable probiotic microsphere compositions and their methods of preparation
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
GB0330009D0 (en) * 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
CA2623968C (en) 2005-09-29 2014-12-09 Merck Patent Gesellschaft Mit Beschraenkter Haftung Method for stabilising pharmaceutical administration forms comprising microorganisms
DE102005062731A1 (de) * 2005-12-22 2007-06-28 Organobalance Gmbh Neue Lactobacillus Stämme und deren Verwendung
TR200800634A2 (tr) * 2008-01-30 2009-02-23 Takka Sevgi̇ Uzatılmış salım sağlayan fluvastatin tablet.
CA2808610C (en) * 2010-08-10 2018-09-25 R.P. Scherer Technologies, Llc Process of manufacturing a stable softgel capsule containing microencapsulated probiotic bacteria
CN104095180A (zh) * 2013-04-12 2014-10-15 中国科学院烟台海岸带研究所 一种益生菌菊粉片及其制备方法
US10583420B2 (en) * 2014-10-01 2020-03-10 7905122 Canada Inc. Process and apparatus for manufacturing water-absorbing material and use in cat litter
WO2016178775A1 (en) * 2015-05-01 2016-11-10 Microbiome Health Research Institute Inc. Compositions and methods for therapeutic delivery of microbial communities
CN104922158B (zh) * 2015-06-05 2018-11-02 中国人民解放军第三军医大学第三附属医院 粪菌胶囊及其制备与应用
US10905726B2 (en) 2015-06-09 2021-02-02 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
CN109414048B (zh) * 2016-06-30 2023-09-01 弗门尼舍有限公司 包衣酵母配方
US20200147151A1 (en) * 2017-01-30 2020-05-14 The Board Of Regents Of The University Of Texas System Compositions and methods for fecal microbiota transplantation
US20200188310A1 (en) 2017-08-29 2020-06-18 Chr. Hansen A/S Stable capsules with fecal microbiota or a culture of microorganisms
CN108567799A (zh) * 2018-08-01 2018-09-25 中国人民解放军总医院 一种全粪菌复合胶囊及其制备方法和应用
EP3955899B1 (en) 2019-04-15 2025-05-07 Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS) Long-term stable live microbiota composition

Also Published As

Publication number Publication date
KR20210152505A (ko) 2021-12-15
EP4609873A2 (en) 2025-09-03
EP3955899B1 (en) 2025-05-07
PT3955899T (pt) 2025-07-18
EA202192291A1 (ru) 2022-02-11
DK3955899T3 (da) 2025-08-04
BR112021020606A2 (pt) 2021-12-07
AU2020259740B2 (en) 2025-12-18
AU2020259740A1 (en) 2021-10-28
MX2021011246A (es) 2022-01-18
IL287238A (en) 2021-12-01
SG11202110641XA (en) 2021-10-28
JP2022529008A (ja) 2022-06-16
EP4609873A3 (en) 2025-11-12
CN113710237A (zh) 2021-11-26
CN113710237B (zh) 2026-04-03
WO2020212297A1 (en) 2020-10-22
EP3955899A1 (en) 2022-02-23
PH12021552573A1 (en) 2022-07-04
US20240131085A1 (en) 2024-04-25
US12521422B2 (en) 2026-01-13
PL3955899T3 (pl) 2025-09-22
CA3130816A1 (en) 2020-10-22
ES3035981T3 (en) 2025-09-11
US20220143107A1 (en) 2022-05-12

Similar Documents

Publication Publication Date Title
FI3955899T3 (fi) Pitkäaikaisesti vakaa, elävä mikrobiotakoostumus
RU2485942C2 (ru) Бупропиона гидробромид и его терапевтические применения
KR101612197B1 (ko) 부프로피온 염산염을 함유하는 안정화된 정제 및 이의 제조방법
FI2346495T4 (fi) Farmaseuttinen formulaatio 514
CY1119839T1 (el) Στερεες μορφες δοσεως μπενταμουστινης
CA2464578A1 (en) Pharmaceutical containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol and providing delayed release of the active ingredient
RU2014101227A (ru) Композиция покрытия, подходящая для фармацевтических или нутрицевтических лекарственных форм
EA201171109A1 (ru) Новая композиция замедленного высвобождения соединений, выбранных из класса миорелаксантов центрального действия
RU2019138248A (ru) Фармацевтическая композиция для перорального введения, содержащая энзалутамид
JP2022529008A5 (https=)
IL276942B1 (en) Enteric softgel capsules
JP2017523149A5 (https=)
RU2014126879A (ru) Композиции акампросата, способы их применения и содержащие их комбинации
MX2008010879A (es) Composiciones farmaceuticas de sodio de fluvastatina.
RU2011134713A (ru) Фармацевтические композиции, включающие пролекарство ингибитора полимеразы hcv
RU2013150254A (ru) Пероральный твердый препарат комбинированного противотуберкулезного лекарственного средства и способ его получения
NO20055601L (no) Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer
RU2016127361A (ru) Гастроретентивные фармацевтические композиции для перорального введения
RU2008115582A (ru) Фармацевтическая композиция для лечения болезни паркинсона
EA200601285A1 (ru) Нераспадающаяся твёрдая композиция для перорального применения с высокой дозой растворимых в воде лекарственных средств
RU2016106955A (ru) Фармацевтический препарат, содержащий производное аминопиразола
RU2008137778A (ru) Лекарственная форма с модифицированным высвобождением 6-метил-2-этил-3-гидроксипиридина сукцината
RU2013125339A (ru) Фармацевтическая композиция для лечения гепатита с
RU2589840C1 (ru) Гидрофильный гель для раневого покрытия
ES2758198T3 (es) Composiciones analgésicas pulverizables